v3.26.1
Condensed Consolidated Statements of Convertible Preferred Stock & Stockholders' Equity - USD ($)
$ in Thousands
Total
Series A Convertible Preferred Stock
Common stock issuable upon the conversion of Series A convertible preferred stock
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   150,000          
Beginning balance at Dec. 31, 2024   $ 142,820          
Temporary Equity              
Accretion of preferred stock dividends   $ 1,322          
Ending balance (in shares) at Mar. 31, 2025   150,000          
Ending balance at Mar. 31, 2025   $ 144,142          
Beginning balance (in shares) at Dec. 31, 2024       62,390,654      
Beginning balance at Dec. 31, 2024 $ 21,729     $ 61 $ 1,177,045 $ (39) $ (1,155,338)
Increase (Decrease) in Stockholders' Equity              
Stock compensation expense 12,862       12,862    
Issuance of common stock in connection with ESPP (in shares)       21,875      
Issuance of common stock in connection with ESPP 854       854    
Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units (in shares)       494,853      
Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units 2,226     $ 1 2,225    
Accretion of preferred stock dividends (1,322)       (1,322)    
Issuance of common stock upon completion of public offering, net of offering costs (in shares)       587,510      
Issuance of common stock upon completion of public offering, net of offering costs 32,108       32,108    
Foreign currency translation adjustment (2)         (2)  
Net unrealized loss on marketable securities (10)         (10)  
Net loss (49,498)           (49,498)
Ending balance (in shares) at Mar. 31, 2025       63,494,892      
Ending balance at Mar. 31, 2025 18,947     $ 62 1,223,772 (51) (1,204,836)
Beginning balance (in shares) at Dec. 31, 2024   150,000          
Beginning balance at Dec. 31, 2024   $ 142,820          
Temporary Equity              
Accretion of preferred stock dividends 2,671            
Ending balance (in shares) at Jun. 30, 2025     150,000        
Ending balance at Jun. 30, 2025     $ 145,491        
Beginning balance (in shares) at Dec. 31, 2024       62,390,654      
Beginning balance at Dec. 31, 2024 21,729     $ 61 1,177,045 (39) (1,155,338)
Increase (Decrease) in Stockholders' Equity              
Foreign currency translation adjustment (2,106)            
Net loss (96,130)            
Ending balance (in shares) at Jun. 30, 2025       63,913,185      
Ending balance at Jun. 30, 2025 (11,908)     $ 64 1,241,744 (2,248) (1,251,468)
Beginning balance (in shares) at Mar. 31, 2025   150,000          
Beginning balance at Mar. 31, 2025   $ 144,142          
Temporary Equity              
Accretion of preferred stock dividends     $ 1,349        
Ending balance (in shares) at Jun. 30, 2025     150,000        
Ending balance at Jun. 30, 2025     $ 145,491        
Beginning balance (in shares) at Mar. 31, 2025       63,494,892      
Beginning balance at Mar. 31, 2025 18,947     $ 62 1,223,772 (51) (1,204,836)
Increase (Decrease) in Stockholders' Equity              
Stock compensation expense 15,880       15,880    
Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units (in shares)       418,293      
Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units 3,443     $ 2 3,441    
Accretion of preferred stock dividends (1,349)       (1,349)    
Foreign currency translation adjustment (2,104)         (2,104)  
Net unrealized loss on marketable securities (93)         (93)  
Net loss (46,632)           (46,632)
Ending balance (in shares) at Jun. 30, 2025       63,913,185      
Ending balance at Jun. 30, 2025 (11,908)     $ 64 1,241,744 (2,248) (1,251,468)
Beginning balance (in shares) at Dec. 31, 2025   132,500          
Beginning balance at Dec. 31, 2025 $ 130,957 $ 130,957          
Temporary Equity              
Conversion of convertible securities (in shares)   (17,500)          
Conversion of Series A preferred stock redeemable to common stock   $ (17,351)          
Accretion of preferred stock dividends   $ 1,104          
Ending balance (in shares) at Mar. 31, 2026   115,000          
Ending balance at Mar. 31, 2026   $ 114,710          
Beginning balance (in shares) at Dec. 31, 2025 67,205,321     67,205,321      
Beginning balance at Dec. 31, 2025 $ 139,069     $ 67 1,491,675 (796) (1,351,877)
Increase (Decrease) in Stockholders' Equity              
Stock compensation expense 23,099       23,099    
Issuance of common stock in connection with ESPP (in shares)       15,875      
Issuance of common stock in connection with ESPP 1,251       1,251    
Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units (in shares)       936,949      
Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units 6,097     $ 2 6,095    
Tax withholding on vesting of restricted stock (in shares)       (77,643)      
Tax withholding on vesting of restricted stock (8,458)       (8,458)    
Conversion of Series A preferred stock redeemable to common stock (in shares)       364,582      
Conversion of convertible securities 17,351       17,351    
Accretion of preferred stock dividends (1,104)       (1,104)    
Foreign currency translation adjustment 1,784         1,784  
Net unrealized loss on marketable securities (544)         (544)  
Net loss (55,639)           (55,639)
Ending balance (in shares) at Mar. 31, 2026       68,445,084      
Ending balance at Mar. 31, 2026 122,906     $ 69 1,529,909 444 (1,407,516)
Beginning balance (in shares) at Dec. 31, 2025   132,500          
Beginning balance at Dec. 31, 2025 130,957 $ 130,957          
Temporary Equity              
Accretion of preferred stock dividends 2,169            
Ending balance (in shares) at Jun. 30, 2026   115,000 115,000 68,816,868      
Ending balance at Jun. 30, 2026 $ 114,318 $ 114,300 $ 114,318        
Beginning balance (in shares) at Dec. 31, 2025 67,205,321     67,205,321      
Beginning balance at Dec. 31, 2025 $ 139,069     $ 67 1,491,675 (796) (1,351,877)
Increase (Decrease) in Stockholders' Equity              
Foreign currency translation adjustment 793            
Net loss $ (104,937)            
Ending balance (in shares) at Jun. 30, 2026 68,816,868            
Ending balance at Jun. 30, 2026 $ 102,983     $ 69 1,560,640 (912) (1,456,814)
Beginning balance (in shares) at Mar. 31, 2026   115,000          
Beginning balance at Mar. 31, 2026   $ 114,710          
Temporary Equity              
Accretion of preferred stock dividends     1,065        
Declaration of preferred stock dividends to be paid in cash     $ (1,457)        
Ending balance (in shares) at Jun. 30, 2026   115,000 115,000 68,816,868      
Ending balance at Jun. 30, 2026 114,318 $ 114,300 $ 114,318        
Beginning balance (in shares) at Mar. 31, 2026       68,445,084      
Beginning balance at Mar. 31, 2026 122,906     $ 69 1,529,909 444 (1,407,516)
Increase (Decrease) in Stockholders' Equity              
Stock compensation expense 26,056       26,056    
Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units (in shares)       386,582      
Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units 6,997     $ 0 6,997    
Tax withholding on vesting of restricted stock (in shares)       (14,798)      
Tax withholding on vesting of restricted stock (1,257)       (1,257)    
Accretion of preferred stock dividends (1,065)       (1,065)    
Foreign currency translation adjustment (991)         (991)  
Net unrealized loss on marketable securities (365)         (365)  
Net loss $ (49,298)           (49,298)
Ending balance (in shares) at Jun. 30, 2026 68,816,868            
Ending balance at Jun. 30, 2026 $ 102,983     $ 69 $ 1,560,640 $ (912) $ (1,456,814)